New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

IHEvsXLVETF Comparison

ETF 1
IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of
US Health Care
-0.31%
Full IHE fund page
VS
ETF 2
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
-0.31%
Full XLV fund page

iShares U.S. Pharmaceuticals ETF (IHE) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. IHE is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.08% for XLV. IHE is up 4.3% year-to-date (YTD) with +$129M in YTD flows. XLV performs worse with -1.22% YTD performance, and +$922M in YTD flows. Run a side-by-side ETF comparison of IHE and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IHE vs XLV performance and flow charts

Performance

-3.0-2.0-1.00.01.02.03.0%Feb 11Feb 19Feb 26Mar 5

Cumulative Flows

-800 M-600 M-400 M-200 M0 M200 M400 MFeb 11Feb 19Feb 26Mar 5

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
IHE
XLV
-1.82%-2.18%
+5.93%-0.02%
+4.30%-1.22%
+28.47%+6.49%
+63.32%+28.22%
+61.21%+44.77%
Flows
IHE
XLV
+$9M-$726M
+$154M+$102M
+$129M+$922M
+$248M+$101M
+$359M-$4.93B
+$393M+$6.94B
Volatility and drawdown
3M1Y3Y5Y
Volatility
IHE
XLV
+15.86%+13.57%
+20.40%+17.40%
+15.94%+13.59%
+15.80%+14.47%
Max drawdown
IHE
XLV
-4.49%-4.63%
-14.18%-12.43%
-16.04%-17.05%
-16.12%-17.05%
Max drawdown duration
IHE
XLV
10d10d
150d211d
210d444d
669d444d
Trading data

Create an account to view trading data

Join for free
IHE
XLV
Last sale
3/12/2026 at 1:30 PM
$86.66
$150.17
Previous close
03/11/2026
$88.40
$152.85
Consolidated volume
03/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IHE
XLV
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
IHE
XLV
Last price
$86.66
$150.17
1D performance
-1.97%
-1.75%
AuM$1.02 B$40.10 B
E/R0.38%0.08%
Characteristics
IHE
XLV
Management strategyPassivePassive
ProvideriSharesSPDR
BenchmarkDow Jones U.S. Select Pharmaceuticals IndexS&P Health Care Select Sector Index
N° of holdings4657
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 1, 2006December 16, 1998
ESGNoNo
Advertisement
Exposure

Countries

IHE
USA
90.92%
Other
9.08%
XLV
USA
96.98%
Other
3.02%

Sectors

IHE
Health Care
96.19%
Other
3.81%
XLV
Health Care
98.26%
Other
1.74%
Advertisement

Diversification

IHE

Total weight of top 15 holdings out of 15

84.8%
XLV

Total weight of top 15 holdings out of 15

70.12%

Top 15 holdings

Data as of January 31, 2026
IHE
JOHNSON&JOHNSON
23.72%
LILLY
22.21%
MERCK & CO INC
4.78%
BRISTOL-MYERS SQUIBB
4.57%
ZOETIS INC
4.44%
PFIZER
4.36%
ROYALTY PHARMA
4.08%
VIATRIS INC
4.00%
ELANCO ANIMAL HEALTH INC
3.20%
JAZZ PHARMACEUTICALS
2.65%
AXSOME THERA CMN STK
2.09%
CRINETICS PHARMACEUTICALS
1.41%
US45579U1097
1.15%
CORCEPT THERAPEUTICS
1.11%
LIGAND PHARMACEUTICALS
1.02%
XLV
LILLY
14.69%
JOHNSON&JOHNSON
9.77%
ABBVIE
7.03%
MERCK & CO INC
4.88%
UNITEDHEALTH GRP
4.64%
THERMO FISHER SCIENTIFIC
3.88%
ABBOTT LABS
3.39%
AMGEN-T
3.28%
INTUITIVE SURGICAL
3.19%
GILEAD SCIENCES
3.14%
PFIZER
2.68%
BOSTON SCIENTIFIC
2.47%
DANAHER
2.45%
MEDTRONIC PLC
2.36%
STRYKER
2.27%
Frequently asked questions about IHE and XLV

How have the IHE and XLV ETFs performed in 2026?

As of March 11, 2026, IHE is up 4.3% year-to-date (YTD), while XLV has lost -1.22%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: IHE or XLV?

Year-to-date, the IHE ETF saw +$129M in flows, compared to +$922M for XLV.

Which ETF is more volatile: IHE or XLV?

Over the past year, IHE had a volatility of 20.4%, while XLV experienced 17.4%.

Which ETF is bigger: IHE or XLV?

As of March 11, 2026, IHE holds $1.02 B in assets under management (AUM), while XLV manages $40.10 B.

What sectors do the IHE and XLV ETFs invest in?

IHE leans toward sectors like Health Care. Meanwhile, XLV focuses on Health Care.

What are the top holdings of the IHE ETF and XLV ETF?

IHE top holdings include JOHNSON&JOHNSON, LILLY and MERCK & CO INC. XLV holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: IHE or XLV?

IHE holds 56 securities with 84.8% of its assets in the top 15. XLV has 60 securities and a top 15 weight of 70.12%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up